PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29678660-0	2018	Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.	Metformin	0-9	vascular endothelial growth factor A	Homo sapiens	100-104	
29678660-5	2018	Our data also indicated that co-treatment of metformin and quercetin strongly inhibited the VEGF/Akt/PI3K pathway.	Metformin	45-54	vascular endothelial growth factor A	Homo sapiens	92-96	
29678660-7	2018	In conclusion, our findings indicate that the combination therapy of metformin and quercetin exerted synergistic antitumor effects in prostate cancers via inhibition of VEGF/Akt/PI3K pathway.	Metformin	69-78	vascular endothelial growth factor A	Homo sapiens	169-173